Share:
Peer-Reviewed Publication
Pharmacoepidemiol Drug Saf2026;35(9):e70446.September 1, 2026Journal Article

Antidepressant Use During Pregnancy and Birth Outcomes: Analysis From the UK, Norway, and Sweden.

Florence Z Martin1,2,3,4,5, Viktor H Ahlqvist1,6,7, Paul Madley-Dowd1,2,3,8, Michael Lundberg9, Jacqueline M Cohen4,10, Kari Furu4,10, Dheeraj Rai1,2,3,8, Harriet Forbes11, Kayleigh Easey1,12, Siri E Håberg4, Gemma C Sharp1,13, Cecilia Magnusson9, Maria C Magnus1,4
1MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
2Population Health Sciences, University of Bristol, Bristol, UK.
3Centre for Academic Mental Health, University of Bristol, Bristol, UK.
4Centre for Fertility and Health, Norwegian Institute for Public Health, Oslo, Norway.
5Epidemiology and Scientific Strategy, IQVIA, London, UK.
6Department of Biomedicine, Aarhus University, Aarhus, Denmark.
7Institute of Environmental Medicine, Karolinska Institutet, Solna, Sweden.
8NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, UK.
9Department of Global Public Health, Karolinska Institutet, Solna, Sweden.
10Department of Chronic Diseases, Norwegian Institute for Public Health, Oslo, Norway.
11Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
12Department of Psychological Science, University of Bristol, Bristol, UK.
13Department of Psychology, University of Exeter, Exeter, UK.

Abstract

PURPOSE: Although antidepressant use during pregnancy has been linked to adverse birth outcomes such as stillbirth and preterm delivery, existing evidence is conflicting and rarely presents absolute risk estimates. We aimed to assess the association between antidepressant use during pregnancy and birth outcomes, alongside estimates of absolute risk to aid clinical interpretation. METHODS: We cond…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.